Ragan Paula 4
4 · X4 Pharmaceuticals, Inc · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Ragan Paula
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-02-12$1.01/sh−21,695$21,892→ 814,746 total
Footnotes (3)
- [F1]These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2023.
- [F2]Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.97 to $1.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.